Showing results (2591-2600 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 22, 2004
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitusGreg L Plosker, David P FiggittPharmacoeconomics|January 21, 2004
Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritisKatherine A Lyseng-Williamson, Rachel H FosterPharmacoeconomics|November 5, 2004
Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinenceDyfrig A Hughes, Dominique DuboisPharmacoeconomics|April 20, 2005
Oral serotonin receptor agonists: a review of their cost effectiveness in migraineJennifer H Lofland, David B NashPharmacoeconomics|April 20, 2005
Cost-effectiveness model of long-acting risperidone in schizophrenia in the USNatalie C Edwards, Marcia F T Rupnow, Chris L Pashos, et al.Pharmacoeconomics|April 20, 2005
A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in SpainPedro J Tárraga-López, Angel Celada-Rodríguez, Miguel Cerdán-Oliver, et al.Pharmacoeconomics|February 8, 2005
Role of pharmacoeconomic analysis in R&D decision making: when, where, how?Paul MillerPharmacoeconomics|February 8, 2005
Measuring productivity changes in economic evaluation: setting the research agendaMarc Koopmanschap, Alex Burdorf, Karin Jacob, et al.Pharmacoeconomics|February 8, 2005
Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorderKristina Secnik, Andrine Swensen, Maureen J LagePharmacoeconomics|September 15, 2004
Pharmacoeconomic burden of undertreating hypertensionLuca Degli Esposti, Giorgia ValpianiPageof 336